Dynocardia key facts
as of Oct 2026- Developer of a wearable blood pressure monitoring device designed to accurately and continuously measure blood pressure.
- Dynocardia is valued at approximately $12.5M as of Oct 2026 (last reported valuation).
- It has raised $8.3M across 4 recorded rounds; the latest was Seed Round ($1.2M) in Mar 2025.
- Notable investors include US National Science Foundation, National Institutes of Health, NextCorps Luminate, Mayo Clinic Platform, 3DEXPERIENCE Lab — 11 tracked in total.
- Dynocardia has filed 12 Form Ds with the SEC since 2019, most recently Dec 2025 ($4.8M sold to 47 investors).
- Status: Privately Held (backing).
Dynocardia's last reported valuation, Jan 2021. Nothing priced has surfaced since.
- ·The complete investor list: 11 names
- ·Watch Dynocardia: the Monday email on marks, rounds and moves
Dynocardia funding rounds
4 roundsWho backs Dynocardia
11+Membership and data by Private Market View
Dynocardia valuation
Dynocardia's last reported valuation was $12.5 million in Jan 2021. No priced round, secondary trade or fund mark has surfaced since.
How much has Dynocardia raised?
Dynocardia has raised $8.3 million across 4 recorded rounds since 2019. The largest was a $489,999 debt round in Apr 2019; the most recent was a $1.2 million seed round in Mar 2025.
Dynocardia has filed 12 Form Ds with the SEC since 2019, most recently in Dec 2025 ($4.8 million sold to 47 investors).
Dynocardia investors
11 investors are on record for Dynocardia, including US National Science Foundation, National Institutes of Health, NextCorps Luminate and Mayo Clinic Platform. The seed round in Mar 2025 drew 20 investors.
About Dynocardia
Developer of a wearable blood pressure monitoring device designed to accurately and continuously measure blood pressure. The company's technology facilitates a wearable optomechanical sensor that uses a non-invasive method to measure blood pressure continuously and accurately, enabling users to accurately measure respiration, heart rate, and cardiac hemodynamic parameters.
- Sector
- Healthcare
- HQ
- Lowell, MA, United States
- Founded
- 2015
- Employees
- 12
- Website
- dynocardia.care/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.